LRCX Add to watchlist $346.10 +16.18 (+4.90%) Last updated: Jul 15, 2026 02:28
52-Week Range
$346.10
$90.94 $346.10 $438.50

Fundamentals Overview

Lam Research Corporation is in the middle of its 52-week range with premium valuation, trending upward today.

Valuation premium

P/E 64.9 PEG 1.47 P/B 40.86 P/S 19.96

Intrinsic value (DCF)

-86.4% downside vs price

Profitability

Net margin 30.9%

Risk (Beta)

1.81 — higher vol

Earnings & growth

EPS $5.34 Rev +9.3% Profit +14.5% vs prior qtr

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Hold — 59% confidence Risk: High Volatility — Beta 1.81. Consider smaller position size due to higher beta.

Supporting (Buy):

Analyst grade: B+ · Sentiment improving (1 upgrade) · 3M vs S&P 500: +19.9%

Pressures (Sell):

DCF 86.4% downside vs price · Beta 1.81 (elevated)

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$432.82B
P/E (TTM)
64.87
EPS (TTM)
$5.34
Dividend Yield
0.3%
52-Week Range
$90.94 - $438.50
Volume vs Avg
N/A
Beta
1.81

About

Lam Research Corporation is a prominent supplier of equipment vital for semiconductor processing, encompassing its design, production, sales, repair, and ongoing maintenance. These sophisticated systems are fundamental for the creation of integrated circuits. The company's extensive product catalog features a variety of deposition technologies. For tungsten metallization, they provide ALTUS systems that deposit conformal films. SABRE products excel in electrochemical deposition, crucial for copp...
Sector: Technology
Headquarters: US
Employees: 19,000
IPO Date: May 1984
Beta: 1.81 (More volatile than market)

Ratings & Grades at a Glance

Overall rating: B+. Recent institutional grades: majority upgrades. Current institutional positions: Buy: 11, Equal Weight: 3, Outperform: 5, Overweight: 9, Positive: 2.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $47.24; current price is $346.10. That’s a -86.4% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) 64.87
DCF value (model) $47.24 (-86.4% vs price)
PEG (TTM) 1.47
P/B (TTM) 40.86
P/S (TTM) 19.96
P/FCF (TTM) 67.1
Liquidity & enterprise
Current Ratio (TTM) 2.54
Quick Ratio (TTM) 1.77
Cash Ratio (TTM) 0.91
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) 30.94%
Gross margin (TTM) 49.98%
Operating margin (TTM) 34.26%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for LRCX.

Analyst Sentiment at a Glance

B+ Sentiment Improving
Buy 11Equal Weight 3Outperform 5Overweight 9Positive 2
1 upgrade, 0 downgrades
Price Target Consensus
Current $346.10
Median $355.00
Consensus $361.06
Low consensus $275.00
High consensus $500.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
Stifel maintain Buy Buy 2026-07-10
Needham maintain Buy Buy 2026-07-10
Mizuho maintain Outperform Outperform 2026-07-09
TD Cowen maintain Buy Buy 2026-07-09
Morgan Stanley maintain Overweight Overweight 2026-07-06
Susquehanna maintain Positive Positive 2026-06-30
Cantor Fitzgerald maintain Overweight Overweight 2026-06-29
B of A Securities maintain Buy Buy 2026-06-23
Wells Fargo maintain Overweight Overweight 2026-06-22
Citigroup maintain Buy Buy 2026-06-17
Oppenheimer maintain Outperform Outperform 2026-06-15
Barclays maintain Equal Weight Equal Weight 2026-06-11
Cantor Fitzgerald maintain Overweight Overweight 2026-06-10
UBS maintain Buy Buy 2026-06-09
Wells Fargo maintain Overweight Overweight 2026-06-01
Mizuho maintain Outperform Outperform 2026-05-27
Morgan Stanley upgrade Equal Weight Overweight 2026-05-18
Needham maintain Buy Buy 2026-04-23
Wells Fargo maintain Overweight Overweight 2026-04-23
TD Cowen maintain Buy Buy 2026-04-23
Barclays maintain Equal Weight Equal Weight 2026-04-23
Citigroup maintain Buy Buy 2026-04-23
B of A Securities maintain Buy Buy 2026-04-23
JP Morgan maintain Overweight Overweight 2026-04-23
RBC Capital maintain Outperform Outperform 2026-04-23
Cantor Fitzgerald maintain Overweight Overweight 2026-04-23
Evercore ISI Group maintain Outperform Outperform 2026-04-23
Stifel maintain Buy Buy 2026-04-23
Susquehanna maintain Positive Positive 2026-04-09
Morgan Stanley maintain Equal Weight Equal Weight 2026-04-06